Selected article for: "clinical trial and MERS cov"
Author: Dawson, Patrick; Malik, Mamunur Rahman; Parvez, Faruque; Morse, Stephen S.
Title: What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review
  • Document date: 2019_3_1
    • ID: yb54i1ne_59
    Snippet: Research on MERS-CoV vaccine candidates is ongoing, and at least one candidate vaccine has now progressed to a Phase I human clinical trial (Modjarrad 2016 , CEPI 2017 . In a promising development, the recently launched Coalition for Epidemic Preparedness Innovations (CEPI) has listed MERS vaccine as one of its initial targets......
    Document: Research on MERS-CoV vaccine candidates is ongoing, and at least one candidate vaccine has now progressed to a Phase I human clinical trial (Modjarrad 2016 , CEPI 2017 . In a promising development, the recently launched Coalition for Epidemic Preparedness Innovations (CEPI) has listed MERS vaccine as one of its initial targets.

    Search related documents:
    Co phrase search for related documents
    • candidate vaccine and Epidemic Preparedness innovation: 1
    • candidate vaccine and human clinical trial: 1, 2, 3, 4, 5
    • candidate vaccine and initial target: 1
    • candidate vaccine and mer vaccine: 1, 2, 3
    • candidate vaccine and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • candidate vaccine and MERS cov vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • candidate vaccine and promising development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • candidate vaccine and vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CEPI Epidemic Preparedness innovation and Epidemic Preparedness innovation: 1
    • CEPI Epidemic Preparedness innovation and MERS cov: 1
    • clinical trial and human clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and initial target: 1
    • clinical trial and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and Phase progress: 1, 2, 3, 4, 5
    • clinical trial and promising development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • clinical trial and vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Epidemic Preparedness innovation and MERS cov: 1
    • Epidemic Preparedness innovation and vaccine candidate: 1
    • human clinical trial and vaccine candidate: 1, 2, 3, 4, 5